D

Daiichi Sankyo ADC

Tokyo, Japan Founded 2005 TSE: 4568
Nanomedicine Cancer Nanotherapy Drug Delivery Protein Nanoparticles Nano-Bio Regenerative Medicine

About

Global pharmaceutical company with leading ADC technology platform

Company Details

Type
public
Employees
16000+
Funding
Public

Key Products

  • Enhertu
  • Dato-DXd
  • HER3-DXd
Visit Website

Related Companies

N

Nanosphere (Luminex)

Northbrook, United States

N

NanoString Technologies

Seattle, United States

N

Nanobiotix

Paris, France

A

Arrowhead Research

Pasadena, United States